-
Reasons to Hope During the COVID-19 Pandemic
Patient advocates learned about COVID-19 and cancer in an AACR virtual forum.
by Kevin McLaughlin
-
Beating the Bully Inside
To gain control over fear of my breast cancer recurring, I called on lessons learned as a 5-year-old confronting the neighborhood bully.
by Joan Harris
-
Cancer Diagnoses and Research Continue
Amid the ongoing pandemic, Cancer Today continues to cover cancer research and treatment while also reporting on the many ways COVID-19 has impacted people with cancer.
by Kevin McLaughlin
-
Planning to Survive
Survivorship care plans can prepare cancer patients to get the best medical care and maintain their quality of life following treatment.
by Carly Flumer
-
Targeted Therapy for Early-Stage Lung Cancer?
A trial of the targeted therapy Tagrisso (osimertinib) for early-stage lung cancer finds that patients who take it go longer without having a cancer recurrence. Whether that should change clinical practice is under discussion.
by Ashley P. Taylor
-
Cervical Cancer Screening Guideline Updated
A new version of the American Cancer Society's cervical cancer screening guideline says screening can start at a later age and highlights human papillomavirus testing as the preferred method.
by Anna Azvolinsky
-
Support Grows for Making Transfusions a Part of Hospice
Blood cancer patients have low rates of enrollment in hospice. One barrier to enrollment is that many hospices do not provide blood transfusions.
by Jon Kelvey
-
A Missed Conversation
Despite national guidelines urging oncologists to bring up risks of infertility posed by cancer treatment, many young cancer patients are never told about these risks or counseled on their fertility preservation options.
by Marcus A. Banks
-
Anal Cancer Diagnoses and Deaths Are Rising in the U.S.
Study underscores importance of early detection and prevention.
by Jane Langille
-
In It for the Long Haul
Doctors and researchers met online to discuss how the coronavirus pandemic changed cancer care in its early months, as well as how they can improve care and advocate for patients going forward.
by Kate Yandell
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles